DesignWrite

From Powerbase
Jump to: navigation, search
Pharma badge.jpg This article is part of the Pharma_Portal project of SpinWatch.

DesignWrite is a medical communications company providing 'science-based educational programs', 'communication of trends in diagnosis and therapy' and 'creative prelaunch and market expansion programs'.[1]

Contents

Ghostwriting for Wyeth

Internal corporate documents show how Wyeth and DesignWrite worked together to create articles promoting hormone therapy therapy (HRT) from 1997. One article appeared in the The American Journal of Obstetrics and Gynecology published by Elsevier as an “Editors’ Choice” feature in 2003 claiming there is '"no definitive evidence" that progestins cause breast cancer and added that hormone users had a better chance of surviving cancer.' [2] The drug company's HRT drug, Prempro, is a combination of estrogen and progestin.[3] The publication supporting Prempro was "authored" by Dr. John Eden, but documents show how Wyeth suggested Dr. Eden write the paper and wrote the outline and draft of the manuscript for him.[4]

Contact

Address:
175 Wall Street
Princeton, NJ 08540 USA
Tel - 609.924.1116
Fax - 609.924.6648
Website: http://www.dwrite.com/

Resources

Notes

  1. DesignWrite. DesignWrite. Accessed 4 March 2010.
  2. Wilson, D. 12 December 2008. The New York Times. Drug Maker Said to Pay Ghostwriters for Journal Articles Accessed 6 March 2010.
  3. Wilson, D. 12 December 2008. The New York Times. Drug Maker Said to Pay Ghostwriters for Journal Articles Accessed 6 March 2010.
  4. Wilson, D. 12 December 2008. The New York Times. Drug Maker Said to Pay Ghostwriters for Journal Articles Accessed 6 March 2010.
Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox